AGENDA

May 10–11, 2023 · Boston, MA
Boston Convention and Exhibition Center

Expand All +

  • Day 1

    May 10, 2023

  • Day 2

    May 11, 2023

  • Engineers are critical to all medtech advancement, but start-ups rely on their problem-solving capabilities more than most. In this panel we’ll hear the state of engineering entrepreneurship – engineerpreneurship? - from several different perspectives including investors, career experts and working engineers who can report the state of start-up engineering from the front lines. Is the start-up life for you?
    Keynote

  • Becton, Dickinson and Company has undergone seismic changes over the past few years. In this interview, Tom Polen, Chairman, CEO and President of BD will share his vision and strategy to focus on growth and transforming the company around the three forces that are reshaping healthcare: smart connected care, enabling the transition to new care settings and improving chronic disease outcomes. We’ll also dive into the role MedTech is playing in the digital transformation of healthcare, including the rise of automation, robotics and AI in pharmacy, lab and healthcare settings.
    Keynote

  • Explore the expo floor and visit with our exhibitors.

  • Medtech Innovator, the largest medical technology accelerator in the world, has invited top graduates of its program to present their exciting stories to investors, potential partners and other start-up executives.

    Presenting companies:

    Augment Health - Augment Health is a medical technology company developing the first active bladder monitoring platform to support urologists in treating the 7 million neurogenic bladder patients in the US.

    Day Zero Dianostics, Inc. - Revolutionizing Infectious Disease Diagnostics using Next Generation Sequencing and Machine Learning.

    DermaSensor, Inc. - DermaSensor Inc. is a health technology company designing non-invasive tools to better equip primary care physicians for skin cancer detection.

    Fibralign Corp - Fibralign Corp's BioBridge is a novel therapeutic device in early commercial stage for the treatment and prevention of lymphedema, a global chronic disease that currently has no cure.

    Limax Biosciences, Inc. - Limax Biosciences has developed a next generation, stretchable hydrogel-based tissue adhesive to transform treatments for injuries inside and outside the body.

    Liquet Medical Inc. - The Versus™ Catheter, by Liquet Medical Inc. is an intelligent drug delivery system for Pulmonary Embolism allowing for personalized patient care through real-time hemodynamics monitoring, increasing speed to treatment, and lowering hospital costs.

    RevBio - RevBio is the innovator of TETRANITE®, a patented regenerative adhesive biomaterial that has been bioengineered for a body of applications to transform bone repair.

    My01 - MY01 helps make trauma outcomes more predictable by providing objective data to manage complex fracture patients.
    Innovation & Investment
    Where
    Room 159

  • An interactive panel discussion and review of the challenges and opportunities in developing the market and introducing a novel, motion-preserving solution to restore daily life for underserved pediatric scoliosis patients and their families.
    Engineering, Product Development

  • Huma have been able to deploy their technology with partners to impact over 3M users across 3000 hospitals. During this interview, Tom & Alex will discuss Huma's learnings from working alongside some of the most prominent players in the industry (such as Smith & Nephew, J&J and Boston Scientific) across the past decade to deliver projects for R&D, Market Access and Commercial. Gilbert will share an honest view of the successes, failures, learnings and opportunities of employing digital health end-to-end and driving value for Medtech.
    Manufacturing, Materials, Sourcing

  • Zimmer Biomet’s Chief Science, Technology and Innovation Officer, Nitin Goyal, discusses how the global medtech leader is finding customer-centric solutions to drive meaningful innovation in the orthopedics space.
    Getting Medtech to Market

  • How can we ensure that MedTech innovation not only enhances patient outcomes but also contributes to a sustainable future? Healthcare's climate footprint is equivalent to >4% of net global carbon emissions, and single use products are on the rise, so there is a pressing need for change. Join us for a thought-provoking discussion on how sustainable design principles can be integrated into medical technology development, highlighting the potential benefits for patients, healthcare providers, and the planet. Discover what we can learn from other market sectors that have already adopted more sustainable principles, informing the role that you can play in building a more resilient and responsible healthcare industry. As an illustration of the potential impact, we will look at high volume diagnostic testing and consider the different aspects of sustainability from manufacture to disposal, looking to the future beyond incremental improvements.
    Engineering, Product Development

  • Intellectual Property (IP) is critical for medical technology companies to attract funding and exits, whether M&A or IPO. Learn best practices and pitfalls to avoid to build strategic patent portfolios to close funding, stay competitive, and secure a successful exit. VCs and CEOs will also discuss how to position your medtech company to attract investors, collaborators, and partners.
    Innovation & Investment

  • MedTech companies spend as much as 40% of revenues on sales efforts. Hear how companies like OSSIO and Embody, Inc. are driving down that cost with a smarter commercial strategy that leverages data and software to better understand target markets, surface top opportunities, and grow their business.
    Getting Medtech to Market

  • Medtronic Neurovascular recently launched its Remote Connectivity Program, powered by Avail’s telepresence technology. In this session you’ll learn more about this comprehensive program and how Medtronic Neurovascular will leverage Avail to enable a closer partnership between its employees and health care providers and ultimately help enable the delivery of better patient care.

  • Explore the expo floor and visit with our exhibitors.

  • Medtech Innovator, the largest medical technology accelerator in the world, has invited top graduates of its program to present their exciting stories to investors, potential partners and other start-up executives.

    Presenting companies:

    Corveus Medical - Corveus Medical is developing a pressure-relief therapy for heart failure patients through a targeted, minimally invasive nerve ablation procedure.

    LiveMetric - LiveMetric is the only FDA-cleared, calibration-free, cuff-free, continuous blood pressure wearable that provides thousands of measurements per month that are digitally transmitted to a provider from which important care and treatment decisions can be made

    Meacor - Meacor is developing a novel anchoring catheter that uses on-demand cryoadhesion for the treatment of mitral and tricuspid valve.

    MonarchBio - MonarchBio’s Titan Flow Diverter is being readied for a human clinical trial and leverages Thin Film Nitinol (TFN) technology to achieve faster and more reliable aneurysm occlusion than competing products.

    Respirix / Cardiospire - Respirix's Cardiospire technology is a new approach to noninvasive hemodynamic monitoring using airway pressure for continuous, high-fidelity modeling of stroke volume and pulmonary artery pressures.

    Safebeat Rx - At SafeBeat, we make machine learning software that powers a cardiac telemetry hospitalization at home.
    Innovation & Investment
    Where
    Room 159

  • More advanced heart failure patients could benefit from left ventricular assist devices (LVADs) than are being offered the option. The life-prolonging technology like Abbott’s HeartMate™ 3 is clinically proven to extend life to five years and beyond, yet there are an estimated 15,000 advanced heart failure patients whose median lifespan remains under a year. Social determinants of health are also a critical factor affecting underserved communities who are not being referred early enough. This important message will be illustrated with the inclusion of a LVAD-to-transplant patient on the panel who will share his story from heart failure diagnosis to the seven years of LVAD support that got him to transplant.
    Getting Medtech to Market

  • Tim Laske, Ph.D., Vice President of Research and Business Development, Cardiac Ablation Solutions, will present on the history, knowledge and evolution of nitinol across Medtronic. In this presentation he’ll share how the company has led the way in evolving the application of nitinol within the heart and vasculature, leveraging understanding of its unique properties (flexibility, durability, etc.). He’ll also discuss why Medtronic chose nitinol for Sphere-9, including the considerations around its capabilities and structure within this novel catheter.
    Manufacturing, Materials, Sourcing

  • A growing body of scientific evidence and validation has demonstrated the value of Virtual Reality (VR) vs. Traditional Training across various healthcare specialties. FundamentalVR is a healthcare technology company working at the intersection of immersive technology using VR, haptics (the sense of touch), and machine learning.

    Through its platform that facilitates remote and immersive medical training, medical device, pharmaceutical companies, and healthcare systems are able to enhance skills acquisition and training globally, and as a result accelerate product adoption and drive significant cost savings.

    The session will demonstrate the value of VR and Haptic feedback using real life examples and case studies.
    Engineering, Product Development

  • For technologies developed in university, hospital or other academic settings, it is critical to the success of both parties (sponsor institution and spin out company) that the technology be properly licensed to the company with terms that mutually align the party's interests and will be acceptable to downstream investors, partners, and/or acquirers. Join for a discussion of effective strategies for structuring and negotiating these critical agreements.
    Innovation & Investment

  • Learn about advancements in wireless power and recharging for the next generation of active implantable devices. Unlock new markets, expand your patient population, and strengthen your competitive advantage with these actionable insights.
    Getting Medtech to Market

  • Characterizing the hazards of medical devices has always been a challenge. Materials are at the core challenge as supply chain disruptions have led to the need to alter materials in order to continue production of critical devices. The understanding of toxicology and the effect of chemistry on the human body is evolving in real-time. When you combine all these factors into an industry that is classically slow to alter the charted course – it leads to a perfect storm. We will take a look at what this means to the industry based on our belief that engineering, material selection, and biocompatibility are a three-legged stool in which each has to be effectively balanced all along the way of device manufacturing.
    Manufacturing, Materials, Sourcing

  • In the field of medtech, simulation is revolutionizing patient care by enabling more precise, effective, and efficient healthcare. Companies along all points in the healthcare supply chain are using dynamic, digital representations of their patients, which we refer to as virtual twins, from pre-operative planning to post-operative monitoring. They are able to simulate and test treatments on virtual cohorts when in development and use streams of real-world data fed from sensors to the virtual twin when used in clinical trials and ongoing care. These insights allow medtech organizations to more efficiently bring new products to market, treat and manage patient conditions, improve outcomes and reduce costs. Most importantly, they are essential to creating true patient centric care, allowing the individual to understand their disease, treatment progress and take a proactive approach across the care continuum. This session provides an overview of the progress and visionary potential of Virtual Twins in medtech and highlights the key benefits and challenges of its adoption.

    Learning outcomes for attendees:
    - How this technology can create scale to reach more patients
    - How this technology can anticipate and optimize for patient outcomes
    - How to engage in a collaborative partnership with tech companies to be a part of building this world together.
    Engineering, Product Development

  • Explore the expo floor and visit with our exhibitors.

  • In this interview, DeviceTalks Editorial Director Tom Salemi will interview CEO Mike Mahoney about the course Boston Scientific has taken to emerge as a global medical device leader. Mahoney brings unique perspectives on leadership, risk tasking and knowing when to let a perceived opportunity go.
    Keynote

  • Engineering, high-level imaging, data-collection and analysis are set to boost surgical outcomes by elevating surgeon precision and performance. But how does will these varied technologies – robotics, digital imaging, VR and data analytical tools – mesh? We’ll hear from leaders representing each of those technologies about how the OR of the future will operate.
    Keynote

  • Johnson & Johnson, one of the world’s leading healthcare companies, gives an inside look at the end-to-end development of its Monarch and Ottava robotics platforms, as well as strategy and innovation cadence across surgical robotics for MedTech.
    Keynote

  • Urologists face some of the greatest demand, strain and burnout among medical professionals. The delta between procedure demand and available urologists is significant, and more professionals are retiring from the field than joining it. What role can smarter device development play in helping to address their challenges? Boston Scientific executives Meghan Scanlon, senior vice president and president of Urology, and Kristin LaRocca, senior vice president of Urology sales, dive into the development of the company’s single-use ureteroscope portfolio to highlight concrete ways that device manufacturers can innovate to address major unmet needs, from infection prevention and reprocessing time saved to OR efficiency and, with the launch of LithoVue Elite, more meaningful data than ever before with the ability to measure intra-renal pressure during the procedure—an insight that could possibly help to address sepsis concerns in the future.
    Engineering, Product Development

  • Explore the expo floor and visit with our exhibitors.

  • Medtech Innovator, the largest medical technology accelerator in the world, has invited top graduates of its program to present their exciting stories to investors, potential partners and other start-up executives.

    Presenting Companies:

    Alva Health, Inc. - Alva Health is developing a non-invasive wearable device for real-time stroke detection

    Forcen - A digital sense of touch in logistics, surgical, & industrial robotics

    Lazurite - Lazurite’s ArthroFree® System is the first wireless surgical camera with FDA market clearance for arthroscopy and general endoscopy.

    MindMics Inc. - MindMics provides an innovative solution to heart monitoring with our patented in-ear infrasonic hemodynography technology, integrated into everyday earbuds and clinically validated, delivering accurate and non-invasive heart monitoring

    PhotoPharmics - PhotoPharmics features an FDA Breakthrough device which resolves large, unmet needs, is based on proven mechanism of action, and is ready to start a pivotal trial.

    Prapela - Prapela is introducing the first mattress pad to help babies breathe.

    Sonavex, Inc. - Sonavex is a venture-backed clinical stage medtech company spun out from Johns Hopkins with technology that uses deep learning to reduce dangerous and expensive central venous catheter time for dialysis patients.
    Innovation & Investment
    Where
    Room 159

  • Evidence-based medicine aims to ensure that only the best diagnostics and therapeutics are available to patients in clinical practice. While randomized controlled trials remain the gold standard of clinical evidence, real-world evidence has recently grown in relevance and importance. Spanning sources including electronic medical records, disease registries, insurance claims and consumer wearables, real-world evidence is increasingly used in support of regulatory approvals and market development. In this session, learn how Philips is using real-world evidence to drive clinical adoption of an innovative diagnostic tool for coronary and peripheral interventions called intravascular ultrasound – and how their experience could contribute to your technology’s evidence strategy.
    Engineering, Product Development

  • The Olympus Respiratory Business led its US Commercial Marketing Team through significant market and business turbulence in recent years. During this session, we will discuss the strategies deployed to overcome global challenges like the uncertainty, anxiety, and change brought about by the Pandemic. We will also explore strategies to navigate organizational challenges, such as integrating team members after an acquisition and building cohesion across multiple field and office locations. And the resulting company culture adjustments and development of a thriving culture in the ""new normal."" Finally, we will discuss hiring for success and growing a highly aligned team focusing on execution.
    Getting Medtech to Market

  • Join Vicarious Surgical CEO, Adam Sachs, as he discusses his perspectives on the state of surgical visualization today and how software platforms can expand the boundaries of hardware capabilities in surgical robots of the future.
    Manufacturing, Materials, Sourcing

  • Among the many critical issues facing a start-up looking to commercialize a medical device is the choice of a contract manufacturing partner. Our executive panel – comprising both start-up and contract manufacturer perspectives, will raise key points to consider in making this decision. We’ll explore best practices that can lead to savings in time and money, mitigate launch risks, and maximize exit valuations.

  • The medical device industry is facing major headwinds to revenue growth, and many of the challenges are self-inflicted. Sales training that has focused mostly on product and disease-state, messaging campaigns, activity, and rapport-building has left sales professionals ill-equipped to drive results in today’s complex healthcare environment. While more organizations have hired clinicians to diversify their customer-facing teams and help increase product utilization, an aversion to selling is undermining their effectiveness in this new role. A new approach is needed to stem the frustration and turnover and keep revenue growth on target. This session will provide a comprehensive, actionable roadmap for turning “tellers” into valued partners and for equipping everyone with the mindset and skillset for sales success.
    Getting Medtech to Market

  • Real-world data has great promise – but until now, timely insights to inform patient care and regulatory decisions have not been possible. Data has been fragmented, locked behind closed systems, and inaccessible for critical areas like medical device use, making it challenging for life science organizations to carry out safety monitoring and effectiveness studies. But that’s all changing. Medical device makers can now access manufacturer-specific, comprehensive device data linked to longitudinal patient records with deep clinical information to understand the safety and effectiveness of any device. During this session, hear from Truveta about its solution, which offers the most complete and timely picture of US health, with the cleanest data. Learn how leading life science and medical device teams are already unlocking insights.

  • Are you settling for mediocrity and the status quo? For today's medical device manufacturers, conformity as a goal can lead to increased risks and distributed mediocrity throughout the supply chain. Our experts will discuss why some organizations struggle to move past conformity from a quality perspective, and how to best implement a quality organizational mindset.

    You will discover: 1) How to leverage modern technology and real-time data to create a powerful collaboration tool for dramatic reduction in product variability and increase in supplier quality
    2) The evolution of SPC, its new role, and opportunities throughout the entire supply chain.
    3) Enable smooth new product introductions (NPIs) and risk-free transfers of products between manufacturing sites and suppliers through accumulation of product quality intelligence in a shared cloud platform Game changing benefits of advanced analytics, AI, and cloud computing for quality transformation.

    Join us and find out how to move beyond conformity and take your quality standards to the next level.
    Getting Medtech to Market

  • In this discussion a panel of R&D and Marketing leaders from across Stryker will discuss emerging trends in Neurotechnology and how the nine Neuro focused businesses across Stryker are developing clinically differentiated products, therapies, and integrated procedural solutions with customers to advance neurosurgery and transform the lives of patients around the world.

  • In this interview, Dave Hickey, executive vice president and president of the Life Sciences segment, details Becton Dickinson’s growing focus on several areas within life sciences. He’ll discuss the important role of diagnostics in women’s health, vision for specimen collection in new care settings, and current and future trends in diagnostics, including point-of-care and combination testing for infectious diseases.
    Getting Medtech to Market

  • Entrepreneurs interested in better understanding the interests and appetites of investors can hear how these leading medtech investors are committing capital, building companies and feeling about the future.
    Innovation & Investment
    Where
    Room 159

  • In this session, attendees will gain a better understanding of the EU MDR extension and how it impacts manufacturers. Other questions to be answered include:

    • What are the pitfalls to avoid during the extension?
    • Learn how notified bodies are dealing with the extensions – common challenges and advice.
    • What is the impact of the extension for legacy v/s new products?
    • What does this mean for Brexit? How will Switzerland act?
    • What is the impact on US medical device reporting (QSR to QMS)

  • Medical devices are used to preserve and improve health, but their use can also negatively impact our environment. While patient care and safety are paramount, companies can often use project timelines, budgets, and regulations to push topics like sustainability and environmental impact to the back burner. A lack of discourse around sustainable processes is a common and unnecessary barrier; companies have much to gain from a broader view of best practices. Canon Virginia, Inc. invites its customers and others in the medical device industry to discuss sustainability openly. This discussion will be an engaging survey of topics ranging from business models to product lifecycle management. Joining Canon Virginia will be Gradian Health Systems, a non-profit medical technology company focused on resource-constrained hospitals worldwide.
    Manufacturing, Materials, Sourcing

  • So where do we go from here? In this session, DeviceTalks Weekly Co-Hosts Tom Salemi and Chris Newmarker review the past two days with Joe Mullings, CEO of the Mullings Group, to pick highlights of the conference and expectations for the Medtech going forward.